Rebounding triad (severe itching, dryness and burning) after facial corticosteroid discontinuation defines a specific class of corticosteroid‐dependent dermatitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1346-8138|42|7|697-702

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.42, Iss.7, 2015-07, pp. : 697-702

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients

By Domingo Christian   Moreno Amalia   José Amengual Ma   Montón Concepción   Suárez David   Pomares Xavier  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 45-53

Informa Healthcare

Access to resources Recommend Favorite

SEVERE PYODERMA FOLLOWING CORTICOSTEROID OCCLUSION

By  

THE JOURNAL OF DERMATOLOGY, Vol. 4, Iss. 4, 1977-08 ,pp. : 157-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cataract and Retinal Detachment in Patients with Severe Atopic Dermatitis Who Were Withdrawn from the Use of Topical Corticosteroid

By  

THE JOURNAL OF DERMATOLOGY, Vol. 26, Iss. 10, 1999-10 ,pp. : 658-665

John Wiley & Sons Inc

Access to resources Recommend Favorite

A step‐down protocol for omalizumab treatment in oral corticosteroid‐dependent allergic asthma patients

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 2, 2018-02 ,pp. : 339-348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eosinophil Activation Status and Corticosteroid Responsiveness in Severe Asthma

By  

International Archives of Allergy and Immunology, Vol. 122, Iss. 3, 2000-07 ,pp. : 200-208

Karger

Access to resources Recommend Favorite